Efficacy and safety of ferric citrate tablets in Chinese patients with hyperphosphatemia undergoing maintenance hemodialysis: a multicenter, randomized, open-label, active-controlled, phase III trial

Jie Ma, Bicheng Liu, Jialiang Pang, Pei Wang, Ying Li, Caili Wang, Donghui Zheng, Xiaoping Wang, Xiumei Hu, Jianrong Zhao, Xinzhou Zhang, Changchun Cao, Zunsong Wang, Li Xing, Suhua Li, Hong Cheng, Jian Huang, Yi Yang, Xiaolan Chen, Kun Ye, Tiekun Yan, Lianhua Chen, Guojuan Zhang, Feng Zheng, Siyuan Teng, Qing Zhu, Hong Liu, Xuemei Li

Open source

DOI: 10.1080/0886022x.2025.2534019
Published: 2026-08-31
Container: Renal Failure
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/0886022x.2025.2534019,
  title = {Efficacy and safety of ferric citrate tablets in Chinese patients with hyperphosphatemia undergoing maintenance hemodialysis: a multicenter, randomized, open-label, active-controlled, phase III trial},
  author = {Jie Ma and Bicheng Liu and Jialiang Pang and Pei Wang and Ying Li and Caili Wang and Donghui Zheng and Xiaoping Wang and Xiumei Hu and Jianrong Zhao and Xinzhou Zhang and Changchun Cao and Zunsong Wang and Li Xing and Suhua Li and Hong Cheng and Jian Huang and Yi Yang and Xiaolan Chen and Kun Ye and Tiekun Yan and Lianhua Chen and Guojuan Zhang and Feng Zheng and Siyuan Teng and Qing Zhu and Hong Liu and Xuemei Li},
  year = {2026},
  journal = {Renal Failure},
  doi = {10.1080/0886022x.2025.2534019},
  url = {https://doi.org/10.1080/0886022x.2025.2534019}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of ferric citrate tablets in Chinese patients with hyperphosphatemia undergoing maintenance hemodialysis: a multicenter, randomized, open-label, active-controlled, phase III trial
AU  - Jie Ma
AU  - Bicheng Liu
AU  - Jialiang Pang
AU  - Pei Wang
AU  - Ying Li
AU  - Caili Wang
AU  - Donghui Zheng
AU  - Xiaoping Wang
AU  - Xiumei Hu
AU  - Jianrong Zhao
AU  - Xinzhou Zhang
AU  - Changchun Cao
AU  - Zunsong Wang
AU  - Li Xing
AU  - Suhua Li
AU  - Hong Cheng
AU  - Jian Huang
AU  - Yi Yang
AU  - Xiaolan Chen
AU  - Kun Ye
AU  - Tiekun Yan
AU  - Lianhua Chen
AU  - Guojuan Zhang
AU  - Feng Zheng
AU  - Siyuan Teng
AU  - Qing Zhu
AU  - Hong Liu
AU  - Xuemei Li
PY  - 2026
JO  - Renal Failure
DO  - 10.1080/0886022x.2025.2534019
UR  - https://doi.org/10.1080/0886022x.2025.2534019
ER  -

APA

Ma, J., Liu, B., Pang, J., Wang, P., Li, Y., Wang, C., Zheng, D., Wang, X., Hu, X., Zhao, J., Zhang, X., Cao, C., Wang, Z., Xing, L., Li, S., Cheng, H., Huang, J., Yang, Y., Chen, X., Ye, K., Yan, T., Chen, L., Zhang, G., Zheng, F., Teng, S., Zhu, Q., Liu, H., & Li, X. (2026). Efficacy and safety of ferric citrate tablets in Chinese patients with hyperphosphatemia undergoing maintenance hemodialysis: a multicenter, randomized, open-label, active-controlled, phase III trial. Renal Failure. https://doi.org/10.1080/0886022x.2025.2534019

Source records

crossref · retrieved 2026-09-26T20:25:12.737Z